Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 6,362 | 6,074 | 0 | 0 | 0 |
| Cost of Goods | 3,173 | 2,008 | N/A | N/A | N/A |
| Gross Profit | 3,189 | 4,066 | N/A | N/A | N/A |
| Operating Expenses | 99,593 | 92,298 | 64,721 | 39,875 | 32,669 |
| Operating Income | -96,231 | -88,224 | -64,721 | -39,875 | -32,669 |
| Interest Expense | 8,589 | 8,480 | 3,314 | 1,019 | 767 |
| Other Income | 493 | 2,357 | 1,297 | -1,317 | 269 |
| Pre-tax Income | -104,327 | -94,347 | -66,738 | -42,211 | -33,167 |
| Net Income Continuous | -104,327 | -94,347 | -66,738 | -42,211 | -33,167 |
| Net Income | $-104,327 | $-94,347 | $-66,738 | $-42,211 | $-33,167 |
| EPS Basic Total Ops | -99.50 | -138.00 | -124.50 | -185.50 | -1,403.50 |
| EPS Basic Continuous Ops | -99.59 | -137.89 | -124.73 | -185.54 | -1,404.19 |
| EPS Diluted Total Ops | -99.50 | -138.00 | -124.50 | -185.50 | -1,403.50 |
| EPS Diluted Continuous Ops | -99.59 | -137.89 | -124.73 | -185.54 | -1,404.19 |
| EPS Diluted Before Non-Recurring Items | -99.50 | -138.00 | N/A | N/A | N/A |
| EBITDA(a) | $-94,265 | $-86,423 | $-64,095 | $-39,121 | $-32,266 |